Showing 1 - 16 results of 16 for search 'Donald R. Branch', query time: 0.04s
Refine Results
-
1
-
2
-
3
In silico analysis suggests repurposing of ibuprofen for prevention and treatment of EBOLA virus disease [v1; ref status: indexed, http://f1000r.es/5bs] by Veljko Veljkovic, Marco Goeijenbier, Sanja Glisic, Nevena Veljkovic, Vladimir R. Perovic, Milan Sencanski, Donald R. Branch, Slobodan Paessler
Published 2015-05-01
Article -
4
Virtual screen for repurposing approved and experimental drugs for candidate inhibitors of EBOLA virus infection [v1; ref status: indexed, http://f1000r.es/51s] by Veljko Veljkovic, Philippe M. Loiseau, Bruno Figadere, Sanja Glisic, Nevena Veljkovic, Vladimir R. Perovic, David P. Cavanaugh, Donald R. Branch
Published 2015-02-01
Article -
5
Using the K/BxN mouse model of endogenous, chronic, rheumatoid arthritis for the evaluation of potential immunoglobulin-based therapeutic agents, including IVIg and Fc-μTP-L309C, a... by Bonnie J. B. Lewis, Jade Ville, Megan Blacquiere, Selena Cen, Rolf Spirig, Adrian W. Zuercher, Fabian Käsermann, Donald R. Branch
Published 2019-12-01
Article -
6
Virtual screen for repurposing approved and experimental drugs for candidate inhibitors of EBOLA virus infection [v2; ref status: indexed, http://f1000r.es/53d] by Veljko Veljkovic, Philippe M. Loiseau, Bruno Figadere, Sanja Glisic, Nevena Veljkovic, Vladimir R. Perovic, David P. Cavanaugh, Donald R. Branch
Published 2015-02-01
Article -
7
Inhibition of in vitro Ebola infection by anti-parasitic quinoline derivatives [version 1; peer review: 2 approved] by Shawn Goyal, Beth Binnington, Stephen D.S. McCarthy, Didier Desmaële, Laurent Férrié, Bruno Figadère, Philippe M. Loiseau, Donald R. Branch
Published 2020-04-01
Article -
8
Small Molecule Drugs That Inhibit Phagocytosis by Melika Loriamini, Melissa M. Lewis-Bakker, Kayluz Frias Boligan, Siming Wang, Mairead B. Holton, Lakshmi P. Kotra, Donald R. Branch
Published 2023-01-01
Article -
9
-
10
Optimal attenuation of experimental autoimmune encephalomyelitis by intravenous immunoglobulin requires an intact interleukin-11 receptor. by Carlyn A Figueiredo, Paulina C Drohomyrecky, Stephen D S McCarthy, Danila Leontyev, Xue-Zhong Ma, Donald R Branch, Shannon E Dunn
Published 2014-01-01
Article -
11
Physical activity and natural anti-VIP antibodies: potential role in breast and prostate cancer therapy. by Milena Veljkovic, Violeta Dopsaj, Milivoj Dopsaj, Donald R Branch, Nevena Veljkovic, Maria M Sakarellos-Daitsiotis, Veljko Veljkovic, Sanja Glisic, Alfonso Colombatti
Published 2011-01-01
Article -
12
-
13
Correction: An activator of G protein-coupled receptor and MEK1/2-ERK1/2 signaling inhibits HIV-1 replication by altering viral RNA processing. by Raymond W Wong, Ahalya Balachandran, Peter K Cheung, Ran Cheng, Qun Pan, Peter Stoilov, P Richard Harrigan, Benjamin J Blencowe, Donald R Branch, Alan Cochrane
Published 2024-04-01
Article -
14
Modular adjuvant-free pan-HLA-DR-immunotargeting subunit vaccine against SARS-CoV-2 elicits broad sarbecovirus-neutralizing antibody responses by Audrey Kassardjian, Eric Sun, Jamie Sookhoo, Krithika Muthuraman, Kayluz Frias Boligan, Iga Kucharska, Edurne Rujas, Arif Jetha, Donald R. Branch, Shawn Babiuk, Brian Barber, Jean-Philippe Julien
Published 2023-04-01
Article -
15
-
16
THP-1 cells transduced with CD16A utilize Fcγ receptor I and III in the phagocytosis of IgG-sensitized human erythrocytes and platelets. by Lazaro Gil Gonzalez, Yuniel Fernandez-Marrero, Peter Alan Albert Norris, Zoya Tawhidi, Yuexin Shan, Yoelys Cruz-Leal, Kevin Doyoon Won, Kayluz Frias-Boligan, Donald R Branch, Alan H Lazarus
Published 2022-01-01
Article